首页 > 最新文献

ISRN obstetrics and gynecology最新文献

英文 中文
Desires, Need, Perceptions, and Knowledge of Assisted Reproductive Technologies of HIV-Positive Women of Reproductive Age in Ontario, Canada. 加拿大安大略省 HIV 阳性育龄妇女对辅助生殖技术的渴望、需求、看法和了解。
Pub Date : 2012-01-01 Epub Date: 2012-08-16 DOI: 10.5402/2012/853503
Yimeng Zhang, Shari Margolese, Mark H Yudin, Janet M Raboud, Christina Diong, Trevor A Hart, Heather M Shapiro, Cliff Librach, Matt Gysler, Mona R Loutfy

The purpose of this cross-sectional study is to assess the desire, need, perceptions, and knowledge of assisted reproductive technologies (ARTs) for women living with HIV (WLWHIV) and determine correlates of ART knowledge desire. WLWHIV of reproductive age were surveyed using the survey instrument "The HIV Pregnancy Planning Questionnaire" at HIV/AIDS service organizations across Ontario, Canada. Of our cohort of 500 WLWHIV, median age was 38, 88% were previously pregnant, 78% desired more information regarding ART, 59% were open to the idea of receiving ART, 39% felt they could access a sperm bank, and 17% had difficulties conceiving (self-reported). Age, African ethnicity, and residence in an urban center were correlated with desire for more ART information. Of participants, 50% wanted to speak to an obstetrician/gynecologist regarding pregnancy planning, and 74% regarded physicians as a main source of fertility service information. While the majority of participants in our cohort desire access to ART information, most do not perceive these services as readily accessible. Healthcare practitioners were viewed as main sources of information regarding fertility services and need to provide accurate information regarding access. Fertility service professionals need to be aware of the increasing demand for ART among WLWHIV.

本横断面研究的目的是评估女性艾滋病病毒感染者(WLWHIV)对辅助生殖技术(ART)的渴望、需求、看法和知识,并确定辅助生殖技术知识渴望的相关因素。我们在加拿大安大略省的艾滋病服务机构使用 "艾滋病妊娠计划问卷 "调查工具对育龄女性艾滋病病毒感染者进行了调查。在我们的 500 名 WLWHIV 群体中,年龄中位数为 38 岁,88% 曾经怀孕过,78% 希望获得更多有关抗逆转录病毒疗法的信息,59% 对接受抗逆转录病毒疗法持开放态度,39% 认为自己可以使用精子库,17% 存在受孕困难(自我报告)。年龄、非洲裔和居住在城市中心与希望获得更多 ART 信息的愿望相关。50%的参与者希望与妇产科医生讨论怀孕计划,74%的参与者认为医生是生育服务信息的主要来源。虽然我们队列中的大多数参与者都希望获得抗逆转录病毒疗法的信息,但大多数人并不认为这些服务很容易获得。医疗从业人员被视为生育服务信息的主要来源,他们需要提供准确的获取信息。生育服务专业人员需要意识到 WLWHIV 对 ART 的需求在不断增加。
{"title":"Desires, Need, Perceptions, and Knowledge of Assisted Reproductive Technologies of HIV-Positive Women of Reproductive Age in Ontario, Canada.","authors":"Yimeng Zhang, Shari Margolese, Mark H Yudin, Janet M Raboud, Christina Diong, Trevor A Hart, Heather M Shapiro, Cliff Librach, Matt Gysler, Mona R Loutfy","doi":"10.5402/2012/853503","DOIUrl":"10.5402/2012/853503","url":null,"abstract":"<p><p>The purpose of this cross-sectional study is to assess the desire, need, perceptions, and knowledge of assisted reproductive technologies (ARTs) for women living with HIV (WLWHIV) and determine correlates of ART knowledge desire. WLWHIV of reproductive age were surveyed using the survey instrument \"The HIV Pregnancy Planning Questionnaire\" at HIV/AIDS service organizations across Ontario, Canada. Of our cohort of 500 WLWHIV, median age was 38, 88% were previously pregnant, 78% desired more information regarding ART, 59% were open to the idea of receiving ART, 39% felt they could access a sperm bank, and 17% had difficulties conceiving (self-reported). Age, African ethnicity, and residence in an urban center were correlated with desire for more ART information. Of participants, 50% wanted to speak to an obstetrician/gynecologist regarding pregnancy planning, and 74% regarded physicians as a main source of fertility service information. While the majority of participants in our cohort desire access to ART information, most do not perceive these services as readily accessible. Healthcare practitioners were viewed as main sources of information regarding fertility services and need to provide accurate information regarding access. Fertility service professionals need to be aware of the increasing demand for ART among WLWHIV.</p>","PeriodicalId":73520,"journal":{"name":"ISRN obstetrics and gynecology","volume":null,"pages":null},"PeriodicalIF":0.0,"publicationDate":"2012-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3431126/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"30887997","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Vaginal use of Ibuprofen isobutanolammonium (ginenorm): efficacy, tolerability, and pharmacokinetic data: a review of available data. 阴道使用布洛芬异丁醇铵(ginenorm):疗效、耐受性和药代动力学数据:对现有数据的回顾
Pub Date : 2012-01-01 Epub Date: 2012-07-09 DOI: 10.5402/2012/673131
Massimo Milani, Piero Iacobelli

Vaginal infection and inflammation with or without vulvar involvement are very common gynecologicaly clinical conditions associated with morbidity and reduced quality of life. Vaginal infections are commonly treated with causal antimicrobial treatments. In addition to specific antimicrobial treatment, anti-inflammatory therapy, both systemic or topical (vaginal douche), could be useful in the integrated treatment approach of these conditions reducing symptoms and speeding up the recovery in vulvovaginitis. Ibuprofen is a well-known effective and well-tolerated anti-COX (anti-COX1 and COX2) compound. In addition, several in vitro studies suggest that Ibuprofen shares antimicrobial and antifungal activities. Ibuprofen isobutanolammonium (Ib-isb) (Ginenorm) is a soluble salt from formulation suitable for external and intravaginal use. This salt completely dissociates in aqueous solution. Ib-isob is available in sachet and vaginal douche pharmaceutical formulations. Clinical efficacy of Ib-isob has been documented in 10 clinical studies (6 controlled and 4 open trials) which have enrolled in total 399 women with vulvovaginitis. The six controlled clinical trials were performed both versus placebo (2 studies) or versus active comparators such as benzydamine. In these studied, Ib-Isb has been used in general for 7 consecutive days with a twice application daily regimen at the dose of 1 g per application. Topical application of Ib-isob induced a marked and rapid reduction in signs (erythema, oedema) and symptoms (itching and burning sensation) of vulvovaginitis. In head-to-head studies carried out in comparison with other topical products, Ib-isob induced a more rapid reduction in both subjective and objective symptoms. In particular a remarkable significant improvement of all the symptoms has been observed in the group of patients treated with Ib-isob in comparison with women receiving benzydamine. The clinical data available for Ib-isob confirm that this salt, specifically developed for gynecological use, is effective and well tolerated in vulvovaginal inflammation conditions. Efficacy of Ib-isob was greater in comparison with commonly used products. Ibuprofen-isob may be considered a useful and effective tool for the topical treatment of nonspecific vaginal diseases.

阴道感染和炎症伴或不伴外阴受累是非常常见的妇科临床状况,与发病率和生活质量降低有关。阴道感染通常采用因果抗菌药物治疗。除了特定的抗菌治疗外,全身或局部(阴道灌洗)的抗炎治疗可用于这些疾病的综合治疗方法,减轻症状并加速外阴阴道炎的恢复。布洛芬是一种众所周知的有效且耐受性良好的抗cox(抗cox1和COX2)化合物。此外,几项体外研究表明,布洛芬具有抗菌和抗真菌活性。布洛芬异丁醇铵(Ib-isb) (Ginenorm)是一种可溶盐,适用于外用和阴道内使用。这种盐在水溶液中完全分解。b-isob可用于小袋和阴道灌洗剂制剂。10项临床研究(6项对照试验和4项开放试验)记录了Ib-isob的临床疗效,这些研究共纳入了399名患有外阴阴道炎的妇女。6项对照临床试验与安慰剂(2项研究)或活性比较物(如苯胺)进行对照。在这些研究中,Ib-Isb一般连续使用7天,每日两次,每次1 g。外阴阴道炎的体征(红斑、水肿)和症状(瘙痒和烧灼感)显著而迅速地减轻。与其他外用产品相比,在进行的头对头研究中,Ib-isob能更快地减轻主观和客观症状。特别是,与接受苄胺治疗的妇女相比,接受b-isob治疗的患者组的所有症状都有显著改善。可获得的Ib-isob临床数据证实,这种专门为妇科开发的盐对外阴阴道炎症条件有效且耐受性良好。与常用产品相比,Ib-isob的疗效更大。布洛芬isob可能被认为是一种有用的和有效的工具,用于局部治疗非特异性阴道疾病。
{"title":"Vaginal use of Ibuprofen isobutanolammonium (ginenorm): efficacy, tolerability, and pharmacokinetic data: a review of available data.","authors":"Massimo Milani,&nbsp;Piero Iacobelli","doi":"10.5402/2012/673131","DOIUrl":"https://doi.org/10.5402/2012/673131","url":null,"abstract":"<p><p>Vaginal infection and inflammation with or without vulvar involvement are very common gynecologicaly clinical conditions associated with morbidity and reduced quality of life. Vaginal infections are commonly treated with causal antimicrobial treatments. In addition to specific antimicrobial treatment, anti-inflammatory therapy, both systemic or topical (vaginal douche), could be useful in the integrated treatment approach of these conditions reducing symptoms and speeding up the recovery in vulvovaginitis. Ibuprofen is a well-known effective and well-tolerated anti-COX (anti-COX1 and COX2) compound. In addition, several in vitro studies suggest that Ibuprofen shares antimicrobial and antifungal activities. Ibuprofen isobutanolammonium (Ib-isb) (Ginenorm) is a soluble salt from formulation suitable for external and intravaginal use. This salt completely dissociates in aqueous solution. Ib-isob is available in sachet and vaginal douche pharmaceutical formulations. Clinical efficacy of Ib-isob has been documented in 10 clinical studies (6 controlled and 4 open trials) which have enrolled in total 399 women with vulvovaginitis. The six controlled clinical trials were performed both versus placebo (2 studies) or versus active comparators such as benzydamine. In these studied, Ib-Isb has been used in general for 7 consecutive days with a twice application daily regimen at the dose of 1 g per application. Topical application of Ib-isob induced a marked and rapid reduction in signs (erythema, oedema) and symptoms (itching and burning sensation) of vulvovaginitis. In head-to-head studies carried out in comparison with other topical products, Ib-isob induced a more rapid reduction in both subjective and objective symptoms. In particular a remarkable significant improvement of all the symptoms has been observed in the group of patients treated with Ib-isob in comparison with women receiving benzydamine. The clinical data available for Ib-isob confirm that this salt, specifically developed for gynecological use, is effective and well tolerated in vulvovaginal inflammation conditions. Efficacy of Ib-isob was greater in comparison with commonly used products. Ibuprofen-isob may be considered a useful and effective tool for the topical treatment of nonspecific vaginal diseases.</p>","PeriodicalId":73520,"journal":{"name":"ISRN obstetrics and gynecology","volume":null,"pages":null},"PeriodicalIF":0.0,"publicationDate":"2012-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://sci-hub-pdf.com/10.5402/2012/673131","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"30798960","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 13
Efficacy and tolerability of fitostimoline (vaginal cream, ovules, and vaginal washing) and of benzydamine hydrochloride (tantum rosa vaginal cream and vaginal washing) in the topical treatment of symptoms of bacterial vaginosis. 局部治疗细菌性阴道病的疗效和耐受性:菲托斯莫林(阴道乳膏、卵泡和阴道洗涤)和盐酸苄胺(蔷薇阴道乳膏和阴道洗涤)。
Pub Date : 2012-01-01 Epub Date: 2012-10-30 DOI: 10.5402/2012/183403
F Boselli, E Petrella, A Campedelli, M Muzi, V Rullo, L Ascione, R Papa, G Saponati

Two hundred and 91 patients showing signs and symptoms of bacterial vaginosis (BV) were randomized to receive topical treatment with Fitostimoline (vaginal cream and vaginal ovules + vaginal washing) or benzydamine hydrochloride (vaginal cream + vaginal washing) for 7 days. Signs (leucorrhoea, erythema, oedema, and erosion) and symptoms (burning, pain, itching, vaginal dryness, dyspareunia, and dysuria) (scored 0-3) were evaluated at baseline and at the end of treatment; the total symptoms score (TSS) was also calculated. In 125 patients, a bacterial vaginosis was confirmed by vaginal swab test. The primary efficacy variable analysis, that is, the percentage of patients with therapeutic success (almost complete disappearance of signs and symptoms), demonstrated that Fitostimoline ovules and vaginal cream were therapeutically equivalent and that pooled Fitostimoline treatment was not inferior to benzydamine hydrochloride. All the treatments were well tolerated, with only minor local adverse events infrequently reported. The results of this study confirmed that gynaecological Fitostimoline is a safe and effective topical treatment for BV.

有细菌性阴道病(BV)体征和症状的291例患者随机接受菲托斯莫林(阴道乳膏和阴道卵泡+阴道冲洗)或盐酸苄胺(阴道乳膏+阴道冲洗)局部治疗,疗程7天。在基线和治疗结束时评估体征(白带、红斑、水肿和糜烂)和症状(灼烧、疼痛、瘙痒、阴道干燥、性交困难和排尿困难)(评分0-3);并计算总症状评分(TSS)。125例患者经阴道拭子试验证实为细菌性阴道病。主要疗效变量分析,即治疗成功(体征和症状几乎完全消失)的患者百分比,表明非托斯莫林卵泡和阴道乳膏在治疗上是等效的,非托斯莫林联合治疗并不亚于盐酸苄胺。所有的治疗都有良好的耐受性,只有很少报道的轻微的局部不良事件。本研究结果证实妇科非托斯莫林是一种安全有效的细菌性阴道炎局部治疗方法。
{"title":"Efficacy and tolerability of fitostimoline (vaginal cream, ovules, and vaginal washing) and of benzydamine hydrochloride (tantum rosa vaginal cream and vaginal washing) in the topical treatment of symptoms of bacterial vaginosis.","authors":"F Boselli,&nbsp;E Petrella,&nbsp;A Campedelli,&nbsp;M Muzi,&nbsp;V Rullo,&nbsp;L Ascione,&nbsp;R Papa,&nbsp;G Saponati","doi":"10.5402/2012/183403","DOIUrl":"https://doi.org/10.5402/2012/183403","url":null,"abstract":"<p><p>Two hundred and 91 patients showing signs and symptoms of bacterial vaginosis (BV) were randomized to receive topical treatment with Fitostimoline (vaginal cream and vaginal ovules + vaginal washing) or benzydamine hydrochloride (vaginal cream + vaginal washing) for 7 days. Signs (leucorrhoea, erythema, oedema, and erosion) and symptoms (burning, pain, itching, vaginal dryness, dyspareunia, and dysuria) (scored 0-3) were evaluated at baseline and at the end of treatment; the total symptoms score (TSS) was also calculated. In 125 patients, a bacterial vaginosis was confirmed by vaginal swab test. The primary efficacy variable analysis, that is, the percentage of patients with therapeutic success (almost complete disappearance of signs and symptoms), demonstrated that Fitostimoline ovules and vaginal cream were therapeutically equivalent and that pooled Fitostimoline treatment was not inferior to benzydamine hydrochloride. All the treatments were well tolerated, with only minor local adverse events infrequently reported. The results of this study confirmed that gynaecological Fitostimoline is a safe and effective topical treatment for BV.</p>","PeriodicalId":73520,"journal":{"name":"ISRN obstetrics and gynecology","volume":null,"pages":null},"PeriodicalIF":0.0,"publicationDate":"2012-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://sci-hub-pdf.com/10.5402/2012/183403","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"31096910","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 8
Qualification of staff, organization of services, and management of pregnant women in rural settings: the case of diema and kayes districts (mali). 工作人员的资格、服务组织和对农村孕妇的管理:以迪马和卡耶斯县为例(马里)。
Pub Date : 2012-01-01 Epub Date: 2012-05-03 DOI: 10.5402/2012/649412
Maman Dogba, Pierre Fournier, Safoura Berthe-Cisse

In Mali, a poor sub-Saharan country, maternity referral systems were implemented to combat the still-high rates of maternal mortality. This qualitative study was aimed at understanding the relationships between the qualification of staff in community health centres, the organization of services, and the management of pregnant women in the maternity referral system in Kayes, a rural region of Mali. Physicians who managed CHCs actively or passively modified work organization, the level of technology, their obstetric skills, and staffing. They also created a competitive environment and developed relationships of trust with patients and with the district health centre. These findings are helpful in orienting decision-making for better personnel management.

马里是一个贫穷的撒哈拉以南国家,该国实施了产妇转诊制度,以应对仍然很高的产妇死亡率。这项定性研究的目的是了解马里农村地区Kayes社区卫生中心工作人员的资格、服务组织和产妇转诊系统中孕妇管理之间的关系。主动或被动管理CHCs的医生改变了工作组织、技术水平、产科技能和人员配置。他们还创造了竞争环境,并与病人和地区保健中心建立了信任关系。这些发现有助于指导更好的人事管理决策。
{"title":"Qualification of staff, organization of services, and management of pregnant women in rural settings: the case of diema and kayes districts (mali).","authors":"Maman Dogba,&nbsp;Pierre Fournier,&nbsp;Safoura Berthe-Cisse","doi":"10.5402/2012/649412","DOIUrl":"https://doi.org/10.5402/2012/649412","url":null,"abstract":"<p><p>In Mali, a poor sub-Saharan country, maternity referral systems were implemented to combat the still-high rates of maternal mortality. This qualitative study was aimed at understanding the relationships between the qualification of staff in community health centres, the organization of services, and the management of pregnant women in the maternity referral system in Kayes, a rural region of Mali. Physicians who managed CHCs actively or passively modified work organization, the level of technology, their obstetric skills, and staffing. They also created a competitive environment and developed relationships of trust with patients and with the district health centre. These findings are helpful in orienting decision-making for better personnel management.</p>","PeriodicalId":73520,"journal":{"name":"ISRN obstetrics and gynecology","volume":null,"pages":null},"PeriodicalIF":0.0,"publicationDate":"2012-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://sci-hub-pdf.com/10.5402/2012/649412","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"30638358","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 6
Laparoscopic surgery in elderly patients aged 65 years and older with gynecologic disease. 65岁及以上老年妇科疾病患者的腹腔镜手术。
Pub Date : 2012-01-01 Epub Date: 2012-11-21 DOI: 10.5402/2012/678201
Haruhiko Kanasaki, Aki Oride, Kohji Miyazaki

Objectives. The study was conducted to characterize the use of the laparoscopic surgery in elderly patients. Methods. The medical records of elderly patients aged ≥65 years who underwent laparoscopic surgery were retrospectively reviewed for diseases, surgical procedures, histological diagnosis, intraoperative and postoperative complications, and reasons for presentation. Results. Of the 405 patients who underwent laparoscopic surgery between January 2005 and March 2012, 41 (10.1%) were aged ≥65 years. The most common disease treated by surgery was ovarian tumor, followed by uterine prolapse. Histological diagnosis of ovarian tumor specimens obtained from 23 patients included serous cystadenoma (44.0%), mature cystic teratoma (20.0%), mucinous cystadenoma (20.0%), and endometrioma (4%). In contrast, in the non-elderly group, the most common histological diagnosis was endometrioma (42.9%), followed in order by mature cystic teratoma (28.3%), serous cystadenoma (18.0%), and mucinous cystadenoma (4.7%). While 23.7% of the non-elderly patients required emergency laparoscopic surgery, none of the elderly patients required emergency surgery. Only 1 of 27 patients who underwent surgery for an ovarian or adnexal mass presented with abdominal pain. No one developed serious intraoperative or postoperative complications. Conclusion. Laparoscopic surgery can be safely performed in elderly patients. It should be noted, however, that few elderly patients with benign pelvic mass manifest symptoms before undergoing surgery.

目标。本研究旨在探讨老年患者腹腔镜手术的特点。方法。回顾性分析≥65岁高龄行腹腔镜手术患者的病历,包括疾病、手术方式、组织学诊断、术中术后并发症及出现原因。结果。在2005年1月至2012年3月期间接受腹腔镜手术的405例患者中,41例(10.1%)年龄≥65岁。手术治疗最常见的疾病是卵巢肿瘤,其次是子宫脱垂。23例卵巢肿瘤标本的组织学诊断包括浆液性囊腺瘤(44.0%)、成熟囊性畸胎瘤(20.0%)、粘液性囊腺瘤(20.0%)和子宫内膜异位瘤(4%)。相比之下,在非老年组中,最常见的组织学诊断是子宫内膜瘤(42.9%),其次是成熟囊性畸胎瘤(28.3%)、浆液性囊腺瘤(18.0%)和粘液性囊腺瘤(4.7%)。23.7%的非老年患者需要急诊腹腔镜手术,而老年患者没有一例需要急诊腹腔镜手术。27例接受卵巢或附件肿块手术的患者中只有1例出现腹痛。无一例发生严重术中或术后并发症。结论。腹腔镜手术可以安全地在老年患者中进行。然而,应该注意的是,很少有良性盆腔肿块的老年患者在手术前表现出症状。
{"title":"Laparoscopic surgery in elderly patients aged 65 years and older with gynecologic disease.","authors":"Haruhiko Kanasaki,&nbsp;Aki Oride,&nbsp;Kohji Miyazaki","doi":"10.5402/2012/678201","DOIUrl":"https://doi.org/10.5402/2012/678201","url":null,"abstract":"<p><p>Objectives. The study was conducted to characterize the use of the laparoscopic surgery in elderly patients. Methods. The medical records of elderly patients aged ≥65 years who underwent laparoscopic surgery were retrospectively reviewed for diseases, surgical procedures, histological diagnosis, intraoperative and postoperative complications, and reasons for presentation. Results. Of the 405 patients who underwent laparoscopic surgery between January 2005 and March 2012, 41 (10.1%) were aged ≥65 years. The most common disease treated by surgery was ovarian tumor, followed by uterine prolapse. Histological diagnosis of ovarian tumor specimens obtained from 23 patients included serous cystadenoma (44.0%), mature cystic teratoma (20.0%), mucinous cystadenoma (20.0%), and endometrioma (4%). In contrast, in the non-elderly group, the most common histological diagnosis was endometrioma (42.9%), followed in order by mature cystic teratoma (28.3%), serous cystadenoma (18.0%), and mucinous cystadenoma (4.7%). While 23.7% of the non-elderly patients required emergency laparoscopic surgery, none of the elderly patients required emergency surgery. Only 1 of 27 patients who underwent surgery for an ovarian or adnexal mass presented with abdominal pain. No one developed serious intraoperative or postoperative complications. Conclusion. Laparoscopic surgery can be safely performed in elderly patients. It should be noted, however, that few elderly patients with benign pelvic mass manifest symptoms before undergoing surgery.</p>","PeriodicalId":73520,"journal":{"name":"ISRN obstetrics and gynecology","volume":null,"pages":null},"PeriodicalIF":0.0,"publicationDate":"2012-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://sci-hub-pdf.com/10.5402/2012/678201","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"31111463","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 4
A Comparative Study of Relationship between Micronutrients and Gestational Diabetes. 微量营养素与妊娠期糖尿病关系的比较研究。
Pub Date : 2012-01-01 Epub Date: 2012-09-04 DOI: 10.5402/2012/470419
Farideh Akhlaghi, Seyyed Majid Bagheri, Omid Rajabi

In this paper, we studied the relation between the micronutrient and gestational diabetes. Therefore, we measured micronutrient concentration including Ni, Al, Cr, Mg, Fe, Zn, Cu, and Se in serum of women with gestational diabetes between 24 and 28 weeks of gestational age (study group) who had inclusion criteria and comparison with micronutrient levels in normal pregnant women with same gestational age (control group). Results showed that there was no significant difference between the serum micronutrient level (Ni, Al, Cr, Mg, Zn, Cu, Se) in study and control groups except serum level of iron which in serum of gestational diabetic women was lower than normal pregnant women and difference was significant.

本文探讨了微量营养素与妊娠期糖尿病的关系。因此,我们测量了具有纳入标准的24 ~ 28周妊娠期糖尿病妇女(研究组)血清中Ni、Al、Cr、Mg、Fe、Zn、Cu和Se的微量营养素浓度,并与相同妊娠期正常孕妇(对照组)的微量营养素水平进行了比较。结果表明:研究组与对照组血清微量营养素(Ni、Al、Cr、Mg、Zn、Cu、Se)水平差异不显著,但妊娠期糖尿病妇女血清铁水平低于正常孕妇且差异显著。
{"title":"A Comparative Study of Relationship between Micronutrients and Gestational Diabetes.","authors":"Farideh Akhlaghi,&nbsp;Seyyed Majid Bagheri,&nbsp;Omid Rajabi","doi":"10.5402/2012/470419","DOIUrl":"https://doi.org/10.5402/2012/470419","url":null,"abstract":"<p><p>In this paper, we studied the relation between the micronutrient and gestational diabetes. Therefore, we measured micronutrient concentration including Ni, Al, Cr, Mg, Fe, Zn, Cu, and Se in serum of women with gestational diabetes between 24 and 28 weeks of gestational age (study group) who had inclusion criteria and comparison with micronutrient levels in normal pregnant women with same gestational age (control group). Results showed that there was no significant difference between the serum micronutrient level (Ni, Al, Cr, Mg, Zn, Cu, Se) in study and control groups except serum level of iron which in serum of gestational diabetic women was lower than normal pregnant women and difference was significant.</p>","PeriodicalId":73520,"journal":{"name":"ISRN obstetrics and gynecology","volume":null,"pages":null},"PeriodicalIF":0.0,"publicationDate":"2012-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://sci-hub-pdf.com/10.5402/2012/470419","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"30913811","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 37
Prognostic significance of vascular endothelial growth factor serum determination in women with ovarian cancer. 卵巢癌妇女血清中血管内皮生长因子测定的预后意义。
Pub Date : 2012-01-01 Epub Date: 2012-06-26 DOI: 10.5402/2012/245756
Elisabetta Bandiera, Roberta Franceschini, Claudia Specchia, Eliana Bignotti, Chiara Trevisiol, Massimo Gion, Sergio Pecorelli, Alessandro Davide Santin, Antonella Ravaggi

Introduction. We performed a review of the literature to elucidate the potential prognostic significance of serum vascular endothelial growth factor (sVEGF) levels in ovarian cancer. Methods. Eligible studies in English and Italian were identified in MEDLINE/PubMed from VEGF discovery to October 2011. All studies evaluating: (i) sVEGF levels before any surgical and chemotherapeutic treatment; (ii) the association between sVEGF levels and the established prognostic variables; (iii) the value of sVEGF levels in predicting patients' outcomes, were selected for this review. Results. The search resulted in 758 titles. Nine studies met the inclusion criteria. A statistically significant association between the level of sVEGF and FIGO stage, tumour grade, residual tumour size, lymph node involvement, and presence of ascites was found in at least one study. sVEGF, in comparison with the established prognostic factors, appears to be the best prognostic marker for overall survival, since it stands out as an independent prognostic factor in most of the studies considered. Moreover, sVEGF levels were shown to be independent prognostic factors by 2 out of the 3 studies that considered DFS as an end point. Conclusion. High levels of sVEGF identify a subgroup of patients with higher risk of death and/or recurrence. These patients should be eligible for individually tailored therapeutic interventions.

简介我们对文献进行了综述,以阐明卵巢癌患者血清血管内皮生长因子(sVEGF)水平的潜在预后意义。研究方法从发现血管内皮生长因子到 2011 年 10 月,在 MEDLINE/PubMed 上找到了符合条件的英语和意大利语研究。本综述选择了所有评估以下内容的研究:(i) 手术和化疗前的 sVEGF 水平;(ii) sVEGF 水平与既定预后变量之间的关联;(iii) sVEGF 水平在预测患者预后方面的价值。结果。通过检索,共找到 758 篇论文。9 项研究符合纳入标准。至少有一项研究发现,sVEGF 水平与 FIGO 分期、肿瘤分级、残余肿瘤大小、淋巴结受累和腹水的存在之间存在统计学意义上的显著关联。此外,在将 DFS 作为终点的 3 项研究中,有 2 项研究表明 sVEGF 水平是独立的预后因素。结论高水平的 sVEGF 可识别出死亡和/或复发风险较高的患者亚群。这些患者有资格接受量身定制的治疗干预。
{"title":"Prognostic significance of vascular endothelial growth factor serum determination in women with ovarian cancer.","authors":"Elisabetta Bandiera, Roberta Franceschini, Claudia Specchia, Eliana Bignotti, Chiara Trevisiol, Massimo Gion, Sergio Pecorelli, Alessandro Davide Santin, Antonella Ravaggi","doi":"10.5402/2012/245756","DOIUrl":"10.5402/2012/245756","url":null,"abstract":"<p><p>Introduction. We performed a review of the literature to elucidate the potential prognostic significance of serum vascular endothelial growth factor (sVEGF) levels in ovarian cancer. Methods. Eligible studies in English and Italian were identified in MEDLINE/PubMed from VEGF discovery to October 2011. All studies evaluating: (i) sVEGF levels before any surgical and chemotherapeutic treatment; (ii) the association between sVEGF levels and the established prognostic variables; (iii) the value of sVEGF levels in predicting patients' outcomes, were selected for this review. Results. The search resulted in 758 titles. Nine studies met the inclusion criteria. A statistically significant association between the level of sVEGF and FIGO stage, tumour grade, residual tumour size, lymph node involvement, and presence of ascites was found in at least one study. sVEGF, in comparison with the established prognostic factors, appears to be the best prognostic marker for overall survival, since it stands out as an independent prognostic factor in most of the studies considered. Moreover, sVEGF levels were shown to be independent prognostic factors by 2 out of the 3 studies that considered DFS as an end point. Conclusion. High levels of sVEGF identify a subgroup of patients with higher risk of death and/or recurrence. These patients should be eligible for individually tailored therapeutic interventions.</p>","PeriodicalId":73520,"journal":{"name":"ISRN obstetrics and gynecology","volume":null,"pages":null},"PeriodicalIF":0.0,"publicationDate":"2012-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3390037/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"30760164","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Predisposing individual characteristics and perinatal outcomes of women in the Tokyo metropolitan area who initiate prenatal care late in their pregnancy: a case-control study. 易感个体特征和围产期结局的妇女在东京大都市区谁开始产前护理在其怀孕后期:一项病例对照研究。
Pub Date : 2012-01-01 Epub Date: 2012-08-08 DOI: 10.5402/2012/945628
Jun Kakogawa, Miyuki Sadatsuki, Takeji Matsushita, Takuro Simbo

Purpose. The purpose of this study was to investigate the individual characteristics and perinatal outcomes of women who initiate prenatal care late in their pregnancy in the Tokyo metropolitan area. Methods. Retrospective study. The study enrolled all women at our hospital who initiated prenatal care after 22 weeks of gestation (late attenders) and control women who initiated prenatal care prior to 11 weeks of gestation participated in the study at the National Center for Global Health and Medicine between January 1, 2007 and June 30, 2011. We compared the maternal characteristics and perinatal outcomes of late attenders with those of the control group. Results. A total of 121 late attenders and 1,787 controls were enrolled. Late attenders had a higher incidence of unmarried compared with the control group (P < 0.01). There were no differences in the incidence of preterm delivery and low birth weight; however, babies of the late attenders had a higher incidence of admission to the neonatal intensive care unit compared with the control group (P < 0.01). Conclusions. Our results indicate that there is a pressing need for further steps to promote the importance of receiving prenatal care during pregnancy.

目的。本研究的目的是调查个体特征和围产期结局的妇女谁在怀孕后期开始产前护理在东京大都市区。方法。回顾性研究。本研究纳入了所有在我院妊娠22周后开始产前护理的妇女(晚期参与者),以及2007年1月1日至2011年6月30日期间在国家全球卫生与医学中心参加研究的妊娠11周前开始产前护理的对照妇女。我们比较了晚出席者的母亲特征和围产期结局与对照组。结果。共有121名迟到者和1,787名对照组被纳入研究。迟到组未婚发生率高于对照组(P < 0.01)。早产和低出生体重的发生率无差异;然而,与对照组相比,晚出席者的婴儿入院新生儿重症监护病房的发生率更高(P < 0.01)。结论。我们的结果表明,有迫切需要进一步的措施,以促进在怀孕期间接受产前护理的重要性。
{"title":"Predisposing individual characteristics and perinatal outcomes of women in the Tokyo metropolitan area who initiate prenatal care late in their pregnancy: a case-control study.","authors":"Jun Kakogawa,&nbsp;Miyuki Sadatsuki,&nbsp;Takeji Matsushita,&nbsp;Takuro Simbo","doi":"10.5402/2012/945628","DOIUrl":"https://doi.org/10.5402/2012/945628","url":null,"abstract":"<p><p>Purpose. The purpose of this study was to investigate the individual characteristics and perinatal outcomes of women who initiate prenatal care late in their pregnancy in the Tokyo metropolitan area. Methods. Retrospective study. The study enrolled all women at our hospital who initiated prenatal care after 22 weeks of gestation (late attenders) and control women who initiated prenatal care prior to 11 weeks of gestation participated in the study at the National Center for Global Health and Medicine between January 1, 2007 and June 30, 2011. We compared the maternal characteristics and perinatal outcomes of late attenders with those of the control group. Results. A total of 121 late attenders and 1,787 controls were enrolled. Late attenders had a higher incidence of unmarried compared with the control group (P < 0.01). There were no differences in the incidence of preterm delivery and low birth weight; however, babies of the late attenders had a higher incidence of admission to the neonatal intensive care unit compared with the control group (P < 0.01). Conclusions. Our results indicate that there is a pressing need for further steps to promote the importance of receiving prenatal care during pregnancy.</p>","PeriodicalId":73520,"journal":{"name":"ISRN obstetrics and gynecology","volume":null,"pages":null},"PeriodicalIF":0.0,"publicationDate":"2012-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://sci-hub-pdf.com/10.5402/2012/945628","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"30863731","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 1
Adverse Outcomes of IVF/ICSI Pregnancies Vary Depending on Aetiology of Infertility. IVF/ICSI妊娠的不良后果因不孕原因而异。
Pub Date : 2012-01-01 Epub Date: 2012-04-09 DOI: 10.5402/2012/451915
Paula Kuivasaari-Pirinen, Kaisa Raatikainen, Maritta Hippeläinen, Seppo Heinonen

In vitro fertilization (IVF) is a risk factor for pregnancy, but there have been few studies on the effect of infertility's aetiology. Thus, we have assessed the role of aetiology on IVF pregnancy outcomes in a retrospective cohort study comparing the outcomes of IVF singleton pregnancies with those of spontaneous pregnancies in the general Finnish population. The study group consisted of 255 women with births resulting from singleton IVF pregnancies. Six subgroups were formed according to the following causes of infertility: anovulation (27%), endometriosis (19%), male factor (17%), tubal factor (15%), polycystic ovary syndrome (11%), and unexplained infertility (12%). The reference group consisted of 26,870 naturally conceived women. Adjusted odds ratios (AORs), for confounding factors such as age and parity, were estimated using logistic regression analysis. Women with endometriosis and anovulation had increased risks of preterm birth (AOR 3.25, 95% CI 1.5-7.1 and AOR 2.1, and 95% CI 1.0-4.2, resp.), while women in couples with male factor infertility had a twofold risk of admission to neonatal intensive care (AOR 2.5, 95% CI 1.2-5.3). The findings show that the aetiology of infertility influenced the obstetrics outcome, and that pooling results may obscure some increased risks among subgroups.

体外受精(IVF)是妊娠的一个危险因素,但对其病因影响的研究很少。因此,我们在一项回顾性队列研究中评估了病因学在体外受精妊娠结局中的作用,该研究比较了芬兰普通人群中体外受精单胎妊娠和自然妊娠的结局。研究小组包括255名通过体外受精单胎分娩的妇女。根据不孕原因分为6个亚组:无排卵(27%)、子宫内膜异位症(19%)、男性因素(17%)、输卵管因素(15%)、多囊卵巢综合征(11%)、不明原因不孕(12%)。参照组由26,870名自然受孕的妇女组成。校正优势比(AORs),如年龄和胎次的混杂因素,估计使用逻辑回归分析。患有子宫内膜异位症和无排卵的妇女早产的风险增加(AOR为3.25,95% CI为1.5-7.1,AOR为2.1,95% CI为1.0-4.2,分别对应),而患有男性因素不育的夫妇中的妇女有两倍的风险进入新生儿重症监护(AOR为2.5,95% CI为1.2-5.3)。研究结果表明,不孕的病因影响产科结果,汇总结果可能会掩盖亚组中一些增加的风险。
{"title":"Adverse Outcomes of IVF/ICSI Pregnancies Vary Depending on Aetiology of Infertility.","authors":"Paula Kuivasaari-Pirinen,&nbsp;Kaisa Raatikainen,&nbsp;Maritta Hippeläinen,&nbsp;Seppo Heinonen","doi":"10.5402/2012/451915","DOIUrl":"https://doi.org/10.5402/2012/451915","url":null,"abstract":"<p><p>In vitro fertilization (IVF) is a risk factor for pregnancy, but there have been few studies on the effect of infertility's aetiology. Thus, we have assessed the role of aetiology on IVF pregnancy outcomes in a retrospective cohort study comparing the outcomes of IVF singleton pregnancies with those of spontaneous pregnancies in the general Finnish population. The study group consisted of 255 women with births resulting from singleton IVF pregnancies. Six subgroups were formed according to the following causes of infertility: anovulation (27%), endometriosis (19%), male factor (17%), tubal factor (15%), polycystic ovary syndrome (11%), and unexplained infertility (12%). The reference group consisted of 26,870 naturally conceived women. Adjusted odds ratios (AORs), for confounding factors such as age and parity, were estimated using logistic regression analysis. Women with endometriosis and anovulation had increased risks of preterm birth (AOR 3.25, 95% CI 1.5-7.1 and AOR 2.1, and 95% CI 1.0-4.2, resp.), while women in couples with male factor infertility had a twofold risk of admission to neonatal intensive care (AOR 2.5, 95% CI 1.2-5.3). The findings show that the aetiology of infertility influenced the obstetrics outcome, and that pooling results may obscure some increased risks among subgroups.</p>","PeriodicalId":73520,"journal":{"name":"ISRN obstetrics and gynecology","volume":null,"pages":null},"PeriodicalIF":0.0,"publicationDate":"2012-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://sci-hub-pdf.com/10.5402/2012/451915","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"30605340","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 67
Methylenetetrahydrofolate Reductase C677T and A1298C Mutations in Women with Recurrent Spontaneous Abortions in the Northwest of Iran. 伊朗西北地区复发性自然流产妇女亚甲基四氢叶酸还原酶C677T和A1298C突变
Pub Date : 2012-01-01 Epub Date: 2012-11-14 DOI: 10.5402/2012/945486
Ahmad Poursadegh Zonouzi, Nader Chaparzadeh, Mehrdad Asghari Estiar, Mahzad Mehrzad Sadaghiani, Laya Farzadi, Alieh Ghasemzadeh, Masoud Sakhinia, Ebrahim Sakhinia

Introduction. Recurrent spontaneous abortion (RSA) is a significant obstetrical complication that may occur during pregnancy. Various studies in recent years have indicated that two common mutations (C677T and A1298C) of the methylenetetrahydrofolate reductase (MTHFR) gene are risk factor for RSA. This study was carried out to determine the influence of (C677T and A1298C) of the methylenetetrahydrofolate reductase (MTHFR) gene mutations with RSA. Materials and Methods. A total of 139 women were included in this study: 89 women with two or more consecutive miscarriages and 50 healthy controls. Total genomic DNA was isolated from blood leukocytes. To determine the frequency of the two common C677T and A1298C MTHFR gene mutations in the patients and controls, we used two methods, amplification refractory mutation system-PCR and PCR-restriction fragment length polymorphism. Results. There is no significant difference in the prevalence of 677T/T genotype among women with RSA and healthy controls (P = 0.285). Also no statistically significant difference in the frequency of A1298C MTHFR gene mutation was detected between the two groups (P = 0.175 ). Conclusion. In conclusion, the results indicate that the Amplification Refractory Mutation System-PCR method was in complete concordance with the results obtained by standard PCR-restriction fragment length polymorphism method. The results also show no significant difference in MTHFR C677T/A1298C genotype distribution among the two groups; therefore, further studies on larger population and other genetic variants to better understand the pathobiology of RSA are needed.

介绍复发性自然流产(RSA)是妊娠期可能发生的一种重要产科并发症。近年来的各种研究表明,亚甲基四氢叶酸还原酶(MTHFR)基因的两个常见突变(C677T和A1298C)是RSA的危险因素。本研究旨在确定亚甲基四氢叶酸还原酶(MTHFR)基因突变的(C677T和A1298C)对RSA的影响。材料和方法。本研究共纳入139名女性:89名连续两次或两次以上流产的女性和50名健康对照。从血液白细胞中分离总基因组DNA。为了确定患者和对照组中两种常见的C677T和A1298C MTHFR基因突变的频率,我们使用了两种方法,扩增难治性突变系统PCR和PCR限制性片段长度多态性。后果RSA患者和健康对照组677T/T基因型的患病率没有显著差异(P=0.285)。两组A1298C-MTHFR基因突变频率也没有统计学显著差异(P=0.0175)。结论总之,结果表明,扩增难治性突变系统PCR方法与标准PCR限制性片段长度多态性方法的结果完全一致。结果还表明,MTHFR C677T/A1298C基因型在两组之间的分布没有显著差异;因此,需要对更大的群体和其他遗传变异进行进一步的研究,以更好地了解RSA的病理生物学。
{"title":"Methylenetetrahydrofolate Reductase C677T and A1298C Mutations in Women with Recurrent Spontaneous Abortions in the Northwest of Iran.","authors":"Ahmad Poursadegh Zonouzi,&nbsp;Nader Chaparzadeh,&nbsp;Mehrdad Asghari Estiar,&nbsp;Mahzad Mehrzad Sadaghiani,&nbsp;Laya Farzadi,&nbsp;Alieh Ghasemzadeh,&nbsp;Masoud Sakhinia,&nbsp;Ebrahim Sakhinia","doi":"10.5402/2012/945486","DOIUrl":"10.5402/2012/945486","url":null,"abstract":"<p><p>Introduction. Recurrent spontaneous abortion (RSA) is a significant obstetrical complication that may occur during pregnancy. Various studies in recent years have indicated that two common mutations (C677T and A1298C) of the methylenetetrahydrofolate reductase (MTHFR) gene are risk factor for RSA. This study was carried out to determine the influence of (C677T and A1298C) of the methylenetetrahydrofolate reductase (MTHFR) gene mutations with RSA. Materials and Methods. A total of 139 women were included in this study: 89 women with two or more consecutive miscarriages and 50 healthy controls. Total genomic DNA was isolated from blood leukocytes. To determine the frequency of the two common C677T and A1298C MTHFR gene mutations in the patients and controls, we used two methods, amplification refractory mutation system-PCR and PCR-restriction fragment length polymorphism. Results. There is no significant difference in the prevalence of 677T/T genotype among women with RSA and healthy controls (P = 0.285). Also no statistically significant difference in the frequency of A1298C MTHFR gene mutation was detected between the two groups (P = 0.175 ). Conclusion. In conclusion, the results indicate that the Amplification Refractory Mutation System-PCR method was in complete concordance with the results obtained by standard PCR-restriction fragment length polymorphism method. The results also show no significant difference in MTHFR C677T/A1298C genotype distribution among the two groups; therefore, further studies on larger population and other genetic variants to better understand the pathobiology of RSA are needed.</p>","PeriodicalId":73520,"journal":{"name":"ISRN obstetrics and gynecology","volume":null,"pages":null},"PeriodicalIF":0.0,"publicationDate":"2012-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://sci-hub-pdf.com/10.5402/2012/945486","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"31094661","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 32
期刊
ISRN obstetrics and gynecology
全部 Acc. Chem. Res. ACS Applied Bio Materials ACS Appl. Electron. Mater. ACS Appl. Energy Mater. ACS Appl. Mater. Interfaces ACS Appl. Nano Mater. ACS Appl. Polym. Mater. ACS BIOMATER-SCI ENG ACS Catal. ACS Cent. Sci. ACS Chem. Biol. ACS Chemical Health & Safety ACS Chem. Neurosci. ACS Comb. Sci. ACS Earth Space Chem. ACS Energy Lett. ACS Infect. Dis. ACS Macro Lett. ACS Mater. Lett. ACS Med. Chem. Lett. ACS Nano ACS Omega ACS Photonics ACS Sens. ACS Sustainable Chem. Eng. ACS Synth. Biol. Anal. Chem. BIOCHEMISTRY-US Bioconjugate Chem. BIOMACROMOLECULES Chem. Res. Toxicol. Chem. Rev. Chem. Mater. CRYST GROWTH DES ENERG FUEL Environ. Sci. Technol. Environ. Sci. Technol. Lett. Eur. J. Inorg. Chem. IND ENG CHEM RES Inorg. Chem. J. Agric. Food. Chem. J. Chem. Eng. Data J. Chem. Educ. J. Chem. Inf. Model. J. Chem. Theory Comput. J. Med. Chem. J. Nat. Prod. J PROTEOME RES J. Am. Chem. Soc. LANGMUIR MACROMOLECULES Mol. Pharmaceutics Nano Lett. Org. Lett. ORG PROCESS RES DEV ORGANOMETALLICS J. Org. Chem. J. Phys. Chem. J. Phys. Chem. A J. Phys. Chem. B J. Phys. Chem. C J. Phys. Chem. Lett. Analyst Anal. Methods Biomater. Sci. Catal. Sci. Technol. Chem. Commun. Chem. Soc. Rev. CHEM EDUC RES PRACT CRYSTENGCOMM Dalton Trans. Energy Environ. Sci. ENVIRON SCI-NANO ENVIRON SCI-PROC IMP ENVIRON SCI-WAT RES Faraday Discuss. Food Funct. Green Chem. Inorg. Chem. Front. Integr. Biol. J. Anal. At. Spectrom. J. Mater. Chem. A J. Mater. Chem. B J. Mater. Chem. C Lab Chip Mater. Chem. Front. Mater. Horiz. MEDCHEMCOMM Metallomics Mol. Biosyst. Mol. Syst. Des. Eng. Nanoscale Nanoscale Horiz. Nat. Prod. Rep. New J. Chem. Org. Biomol. Chem. Org. Chem. Front. PHOTOCH PHOTOBIO SCI PCCP Polym. Chem.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
0
微信
客服QQ
Book学术公众号 扫码关注我们
反馈
×
意见反馈
请填写您的意见或建议
请填写您的手机或邮箱
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
现在去查看 取消
×
提示
确定
Book学术官方微信
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术
文献互助 智能选刊 最新文献 互助须知 联系我们:info@booksci.cn
Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。
Copyright © 2023 Book学术 All rights reserved.
ghs 京公网安备 11010802042870号 京ICP备2023020795号-1